Gil Blum
Stock Analyst at Needham
(4.66)
# 837
Out of 4,609 analysts
713
Total ratings
44.6%
Success rate
13.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Maintained: Buy | $19 | $8.71 | +118.14% | 8 | Aug 7, 2026 | |
| LYEL Lyell Immunopharma | Maintained: Buy | $44 | $14.21 | +209.64% | 6 | Aug 7, 2026 | |
| ARTV Artiva Biotherapeutics | Maintained: Buy | $41 | $11.58 | +254.06% | 16 | Aug 7, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Sell | n/a | $16.78 | - | 56 | Aug 6, 2026 | |
| RNAC Cartesian Therapeutics | Maintained: Buy | $40 | $8.76 | +356.62% | 37 | Aug 6, 2026 | |
| IMCR Immunocore Holdings | Maintained: Buy | $75 | $34.50 | +117.39% | 23 | Aug 6, 2026 | |
| GERN Geron | Maintained: Buy | $4 | $1.57 | +154.78% | 36 | Aug 5, 2026 | |
| RXRX Recursion Pharmaceuticals | Maintained: Buy | $8 | $3.18 | +151.57% | 30 | Aug 5, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | $82 | $51.64 | +58.79% | 42 | Aug 4, 2026 | |
| NRIX Nurix Therapeutics | Maintained: Buy | $34 | $25.22 | +34.81% | 48 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.00 | +400.00% | 51 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $10.06 | +108.75% | 1 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $93.25 | +68.36% | 33 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.49 | - | 23 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.34 | +89.27% | 49 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $11 | $8.30 | +32.53% | 13 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7632 | +686.16% | 17 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 | $2.29 | +380.35% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3059 | +880.71% | 34 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.54 | - | 49 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.16 | - | 28 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.70 | - | 25 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.59 | n/a | 15 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 400.00 → kr 371.00 | kr 174.80 | n/a | 16 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $30.22 | n/a | 14 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $103.42 | n/a | 10 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 5 | Apr 6, 2022 |
Solid Biosciences
Aug 7, 2026
Maintained: Buy
Price Target: $19
Current: $8.71
Upside: +118.14%
Lyell Immunopharma
Aug 7, 2026
Maintained: Buy
Price Target: $44
Current: $14.21
Upside: +209.64%
Artiva Biotherapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $41
Current: $11.58
Upside: +254.06%
Sarepta Therapeutics
Aug 6, 2026
Reiterated: Sell
Price Target: n/a
Current: $16.78
Upside: -
Cartesian Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $40
Current: $8.76
Upside: +356.62%
Immunocore Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $75
Current: $34.50
Upside: +117.39%
Geron
Aug 5, 2026
Maintained: Buy
Price Target: $4
Current: $1.57
Upside: +154.78%
Recursion Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $8
Current: $3.18
Upside: +151.57%
CRISPR Therapeutics AG
Aug 4, 2026
Maintained: Buy
Price Target: $82
Current: $51.64
Upside: +58.79%
Nurix Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $34
Current: $25.22
Upside: +34.81%
Aug 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.00
Upside: +400.00%
Jul 22, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $10.06
Upside: +108.75%
Jul 15, 2026
Reiterated: Buy
Price Target: $157
Current: $93.25
Upside: +68.36%
Jul 10, 2026
Maintained: Hold
Price Target: n/a
Current: $2.49
Upside: -
Jul 1, 2026
Maintained: Buy
Price Target: $12
Current: $6.34
Upside: +89.27%
Jun 24, 2026
Reiterated: Buy
Price Target: $7 → $11
Current: $8.30
Upside: +32.53%
Jun 23, 2026
Reiterated: Buy
Price Target: $6
Current: $0.7632
Upside: +686.16%
May 13, 2026
Rated: Buy
Price Target: $11
Current: $2.29
Upside: +380.35%
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3059
Upside: +880.71%
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $3.54
Upside: -
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $7.16
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $1.70
Upside: -
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $5.59
Upside: n/a
Feb 16, 2023
Reiterated: Buy
Price Target: kr 400.00 → kr 371.00
Current: kr 174.80
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $6
Current: $30.22
Upside: n/a
Aug 25, 2022
Rated: Hold
Price Target: n/a
Current: $103.42
Upside: n/a
Jun 3, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Apr 6, 2022
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a